209 related articles for article (PubMed ID: 12034146)
1. Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis.
Gharib MI; Burnett AK
Eur J Heart Fail; 2002 Jun; 4(3):235-42. PubMed ID: 12034146
[TBL] [Abstract][Full Text] [Related]
2. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.
Pai VB; Nahata MC
Drug Saf; 2000 Apr; 22(4):263-302. PubMed ID: 10789823
[TBL] [Abstract][Full Text] [Related]
3. Cardiotoxicity of chemotherapy.
de Forni M; Armand JP
Curr Opin Oncol; 1994 Jul; 6(4):340-4. PubMed ID: 7803534
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention].
Nelson-Veniard M; Thambo JB
Bull Cancer; 2015; 102(7-8):622-6. PubMed ID: 25935231
[TBL] [Abstract][Full Text] [Related]
5. Cardiotoxicity of cancer chemotherapy: implications for children.
Simbre VC; Duffy SA; Dadlani GH; Miller TL; Lipshultz SE
Paediatr Drugs; 2005; 7(3):187-202. PubMed ID: 15977964
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxicity of doxorubicin and other anthracycline derivatives.
Jain D
J Nucl Cardiol; 2000; 7(1):53-62. PubMed ID: 10698235
[No Abstract] [Full Text] [Related]
7. Natriuretic peptides: biochemical markers of anthracycline cardiac toxicity?
Urbanova D; Urban L; Danova K; Simkova I
Oncol Res; 2008; 17(2):51-8. PubMed ID: 18543606
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy and cardiotoxicity].
Brestescher C; Pautier P; Farge D
Ann Cardiol Angeiol (Paris); 1995 Oct; 44(8):443-7. PubMed ID: 8669796
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity.
Chung WB; Youn HJ
Korean J Intern Med; 2016 Jul; 31(4):625-33. PubMed ID: 27378126
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
Nabati M; Janbabai G; Baghyari S; Esmaili K; Yazdani J
J Cardiovasc Pharmacol; 2017 May; 69(5):279-285. PubMed ID: 28141699
[TBL] [Abstract][Full Text] [Related]
11. [Cardiotoxicity of drugs used in oncology].
Poprach A; Petráková K; Vyskocil J; Lakomý R; Nemecek R; Kocák I; Kocáková I; Vyzula R
Klin Onkol; 2008; 21(5):288-93. PubMed ID: 19202960
[TBL] [Abstract][Full Text] [Related]
12. [Cardiologic sequelae of cytostatic therapy].
Mladosievivcová B
Cas Lek Cesk; 2001 Mar; 140(5):138-41. PubMed ID: 11347200
[TBL] [Abstract][Full Text] [Related]
13. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use.
Dolci A; Dominici R; Cardinale D; Sandri MT; Panteghini M
Am J Clin Pathol; 2008 Nov; 130(5):688-95. PubMed ID: 18854260
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for the early detection of anthracycline-induced cardiotoxicity: current status.
Horacek JM; Vasatova M; Pudil R; Tichy M; Zak P; Jakl M; Jebavy L; Maly J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec; 158(4):511-7. PubMed ID: 24457832
[TBL] [Abstract][Full Text] [Related]
15. Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities.
Vejpongsa P; Yeh ET
J Am Coll Cardiol; 2014 Sep; 64(9):938-45. PubMed ID: 25169180
[TBL] [Abstract][Full Text] [Related]
16. Strategies for prevention of anthracycline cardiotoxicity.
Basser RL; Green MD
Cancer Treat Rev; 1993 Jan; 19(1):57-77. PubMed ID: 8431927
[No Abstract] [Full Text] [Related]
17. Anthracycline-induced cardiotoxicity.
Hrdina R; Gersl V; Klimtová I; Simůnek T; Machácková J; Adamcová M
Acta Medica (Hradec Kralove); 2000; 43(3):75-82. PubMed ID: 11089274
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy.
Madeddu C; Deidda M; Piras A; Cadeddu C; Demurtas L; Puzzoni M; Piscopo G; Scartozzi M; Mercuro G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e12-e18. PubMed ID: 27755238
[TBL] [Abstract][Full Text] [Related]
19. Role of biomarkers in chemotherapy-induced cardiotoxicity.
Cardinale D; Sandri MT
Prog Cardiovasc Dis; 2010; 53(2):121-9. PubMed ID: 20728699
[TBL] [Abstract][Full Text] [Related]
20. Utilizing cardiac biomarkers to detect and prevent chemotherapy-induced cardiomyopathy.
Singh D; Thakur A; Tang WH
Curr Heart Fail Rep; 2015 Jun; 12(3):255-62. PubMed ID: 25869733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
